Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Nectar Life
Nectar Life
BSE: 532649NSE: NECLIFEISIN: INE023H01027

25th-May-2019 17:06Source: BSE

Nectar Lifesciences - Board recommends Final Dividend

Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2019, inter alia, have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the Company, out of profits of the Company for the financial year 2018-2019, subject to the approval of the members in their Annual General
Meeting.

Sections
Follow us on
Available On
PCI DSS Compliant